JP2007534678A - Ｃｃｒ−１アンタゴニストとしての化合物 - Google Patents

Ｃｃｒ−１アンタゴニストとしての化合物 Download PDF

Info

Publication number
JP2007534678A
JP2007534678A JP2007508868A JP2007508868A JP2007534678A JP 2007534678 A JP2007534678 A JP 2007534678A JP 2007508868 A JP2007508868 A JP 2007508868A JP 2007508868 A JP2007508868 A JP 2007508868A JP 2007534678 A JP2007534678 A JP 2007534678A
Authority
JP
Japan
Prior art keywords
chloro
phenyl
oxo
compound
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2007508868A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007534678A5 (https=
Inventor
リシャール・アング
ラズロ・レヴェズ
アヒム・シュラップバッハ
ルドルフ・ヴェルヒリ
Original Assignee
ノバルティス アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバルティス アクチエンゲゼルシャフト filed Critical ノバルティス アクチエンゲゼルシャフト
Publication of JP2007534678A publication Critical patent/JP2007534678A/ja
Publication of JP2007534678A5 publication Critical patent/JP2007534678A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2007508868A 2004-04-26 2005-04-25 Ｃｃｒ−１アンタゴニストとしての化合物 Ceased JP2007534678A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0409236.7A GB0409236D0 (en) 2004-04-26 2004-04-26 Organic compounds
PCT/EP2005/004422 WO2005103054A2 (en) 2004-04-26 2005-04-25 Bridged piperazine and piperidine derivatives as ccri antagonists

Publications (2)

Publication Number Publication Date
JP2007534678A true JP2007534678A (ja) 2007-11-29
JP2007534678A5 JP2007534678A5 (https=) 2010-08-05

Family

ID=32344398

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508868A Ceased JP2007534678A (ja) 2004-04-26 2005-04-25 Ｃｃｒ−１アンタゴニストとしての化合物

Country Status (14)

Country Link
US (1) US20070196270A1 (https=)
EP (1) EP1794164A2 (https=)
JP (1) JP2007534678A (https=)
KR (2) KR100845356B1 (https=)
CN (1) CN101238131A (https=)
AR (1) AR052397A1 (https=)
AU (1) AU2005235724B2 (https=)
BR (1) BRPI0510313A (https=)
CA (1) CA2559917A1 (https=)
GB (1) GB0409236D0 (https=)
MX (1) MXPA06012380A (https=)
RU (1) RU2383548C2 (https=)
TW (1) TW200603805A (https=)
WO (1) WO2005103054A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2712211T3 (es) 2013-06-20 2019-05-09 Bayer Cropscience Ag Derivados de arilsulfuro y arilsulfóxido acaricidas e insecticidas
MX368059B (es) 2013-07-18 2019-09-18 Novartis Ag Inhibidores de autotaxina que comprenden un núcleo de anillo heteroaromático de bencil-amida cíclica.
CN115286637B (zh) * 2022-08-11 2024-03-22 成都金博汇康医药科技有限公司 三氮杂桥环化合物及其中间体化合物、制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056771A2 (en) * 1997-06-12 1998-12-17 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
WO2001042245A1 (en) * 1999-12-08 2001-06-14 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002032901A2 (en) * 2000-10-19 2002-04-25 Pfizer Products Inc. Bridged piperazine derivatives
WO2002036581A1 (en) * 2000-11-06 2002-05-10 Schering Aktiengesellschaft Radiopharmaceuticals for diagnosing alzheimer's disease
WO2004009588A1 (en) * 2002-07-18 2004-01-29 Pfizer Products Inc. Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002100833A1 (ja) * 2001-06-12 2004-09-24 住友製薬株式会社 Ｒｈｏキナーゼ阻害剤
GB0224917D0 (en) * 2002-10-25 2002-12-04 Novartis Ag Organic compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056771A2 (en) * 1997-06-12 1998-12-17 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
WO2001042245A1 (en) * 1999-12-08 2001-06-14 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002032901A2 (en) * 2000-10-19 2002-04-25 Pfizer Products Inc. Bridged piperazine derivatives
WO2002036581A1 (en) * 2000-11-06 2002-05-10 Schering Aktiengesellschaft Radiopharmaceuticals for diagnosing alzheimer's disease
WO2004009588A1 (en) * 2002-07-18 2004-01-29 Pfizer Products Inc. Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor

Also Published As

Publication number Publication date
KR20080015151A (ko) 2008-02-18
US20070196270A1 (en) 2007-08-23
GB0409236D0 (en) 2004-05-26
CN101238131A (zh) 2008-08-06
KR20070014154A (ko) 2007-01-31
MXPA06012380A (es) 2007-01-17
WO2005103054A2 (en) 2005-11-03
RU2383548C2 (ru) 2010-03-10
EP1794164A2 (en) 2007-06-13
AR052397A1 (es) 2007-03-21
AU2005235724A1 (en) 2005-11-03
BRPI0510313A (pt) 2007-10-16
CA2559917A1 (en) 2005-11-03
AU2005235724B2 (en) 2008-10-30
RU2006141702A (ru) 2008-06-10
WO2005103054A3 (en) 2007-02-08
KR100845356B1 (ko) 2008-07-09
TW200603805A (en) 2006-02-01

Similar Documents

Publication Publication Date Title
ES2956555T3 (es) Proceso para la preparación de derivados de imidazol pentacíclicos condensados y usos de los mismos como moduladores de la actividad de TNF
RU2686117C1 (ru) Конденсированные производные имидазола и пиразола в качестве модуляторов активности tnf
JP5121716B2 (ja) ピリジン誘導体および精神異常の処置におけるそれらの使用
TWI829676B (zh) 噁二唑暫時受體電位通道抑制劑
ES2753163T3 (es) Derivados de hexahidropirrolo[3,4-c]pirrol y compuestos relacionados como inhibidores de la autotaxina (ATX) y como inhibidores de la producción de ácido lisofosfatídico (LPA) para tratar, por ejemplo, enfermedades renales
TWI419889B (zh) 吡唑并〔１，５-ａ〕嘧啶化合物
ES2232416T3 (es) Derivados de triazolo-piridazina como ligandos para receptores gaba.
JP7171567B2 (ja) 一過性受容体電位型チャネル阻害剤としてのオキサジアゾロン類
HRP20020328A2 (en) Heteroalkylamino-substited bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
JP2008510770A (ja) Ｐｌｋ阻害剤としての新規プテリジノン
TW201422624A (zh) 作爲ｊａｋ抑制劑之三環稠合噻吩衍生物
CN109996792A (zh) 具有在治疗cns疾病和疼痛中作为毒蕈碱性m1和/或m4受体的调节剂的活性的杂环化合物
JP6862457B2 (ja) ３−（カルボキシメチル）−８−アミノ−２−オキソ−１，３−ジアザ−スピロ−［４．５］−デカン誘導体
CA3134814A1 (en) Tyk2 pseudokinase ligands
WO2004098520A2 (en) Compounds and compositions as protein kinase inhibitors
WO2022194781A1 (en) Heterocyclic derivatives as janus kinase inhibitors
JP2019532948A (ja) 架橋ピペリジン誘導体
TW201738233A (zh) 吲唑之合成
US10793578B2 (en) Fused pentacyclic imidazole derivatives as modulators of TNF activity
JP2012072067A (ja) 含窒素芳香族へテロ環化合物
CN104710423A (zh) Mk2抑制剂
TWI860797B (zh) 新穎acc抑制劑
JPH03204877A (ja) ピラゾロ［１，５―ａ］ピリミジン誘導体
JP2007534678A (ja) Ｃｃｒ−１アンタゴニストとしての化合物
WO2022049253A1 (en) Substituted n-heteroaryl-n-pyridinylacetamides as p2x4 modulators

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100216

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100517

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100524

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100616

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100713

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101012

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101115

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101122

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20101213

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110112

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110419

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20110830